BACKGROUND/ OBJECTIVES: We assessed synthetic cannabinoid (SC) outbreaks from 2011-2012 and 2015. METHODS: The National Poison Data System was utilized to collect reports of SC adverse effects in New York State from 2011-2012 and 2015 (N = 713). RESULTS: Cases from 2015 were more likely to be admitted to intensive care units and had different symptoms than those in 2011-2012. We identified two new SC structural classes from 2015 samples. DISCUSSION/ CONCLUSIONS: The 2015 outbreak was associated with more severe SC-related illnesses than in 2011-2012. SCIENTIFIC SIGNIFICANCE: New SC compounds may pose a different or more severe risk than those previously identified. (Am J Addict 2017;26:772-775).
BACKGROUND/ OBJECTIVES: We assessed synthetic cannabinoid (SC) outbreaks from 2011-2012 and 2015. METHODS: The National Poison Data System was utilized to collect reports of SC adverse effects in New York State from 2011-2012 and 2015 (N = 713). RESULTS: Cases from 2015 were more likely to be admitted to intensive care units and had different symptoms than those in 2011-2012. We identified two new SC structural classes from 2015 samples. DISCUSSION/ CONCLUSIONS: The 2015 outbreak was associated with more severe SC-related illnesses than in 2011-2012. SCIENTIFIC SIGNIFICANCE: New SC compounds may pose a different or more severe risk than those previously identified. (Am J Addict 2017;26:772-775).
Authors: Eric Sparkes; Rochelle Boyd; Shuli Chen; Jack W Markham; Jia Lin Luo; Tahira Foyzun; Humayra Zaman; Charlotte Fletcher; Ross Ellison; Iain S McGregor; Marina J Santiago; Felcia Lai; Roy R Gerona; Mark Connor; David E Hibbs; Elizabeth A Cairns; Michelle Glass; Adam Ametovski; Samuel D Banister Journal: Front Psychiatry Date: 2022-09-28 Impact factor: 5.435